Close Menu

NEW YORK (360Dx) — Digital pathology firm PathAI announced today that it has closed a $60 million Series B financing round.

The round was led by new investor General Atlantic with participation from existing investors including General Catalyst. In conjunction with the round, General Atlantic Managing Director Michelle Dipp will join PathAI's board.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.